Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN104910195B enables efficient difluoromethylation. Stable solid reagent offers supply chain reliability and cost reduction in fine chemical manufacturing for global partners.
Novel catalytic method for 2-aminobiphenyl derivatives using metal phthalocyanines. Offers high purity, mild conditions, and scalable production for agrochemical and pharmaceutical applications.
Patent CN113337494B reveals high-purity enzymatic synthesis reducing waste and cost for reliable pharmaceutical intermediates supply chains globally.
Patent CN112811996B details a metal-free catalytic method for synthesizing chiral ketones with high enantioselectivity, offering cost-effective solutions for pharmaceutical intermediates.
Patent CN109369521B details a green 2-chloroquinoline synthesis using BTC. Discover cost-effective, high-purity manufacturing solutions for pharmaceutical intermediates.
Patent CN105601538B details high-yield cyhalofop-butyl synthesis. Reduces energy and waste for global supply chain efficiency.
Patent CN101445470B reveals a green ionic liquid catalyzed route for polysubstituted benzenes. Achieve high purity and cost reduction in API manufacturing with scalable technology.
Novel ionic liquid catalyzed synthesis offers high purity pharmaceutical intermediates. Reduces cost and environmental impact for scalable commercial production.
Patent CN111662889B discloses a novel ketoreductase mutant enabling efficient synthesis of Darunavir intermediates with high substrate loading and reduced costs.
Patent CN102548959B reveals novel TBIC solvent method enhancing yield and reducing distillation costs for pharmaceutical intermediates manufacturing supply chains.
Patent CN108456227B reveals efficient photocatalytic synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high regioselectivity.
Patent CN101417942B reveals high-purity synthesis route. Enables cost reduction in pharma intermediate manufacturing with scalable chromatography separation.
Patent CN101054351B enables solvent-free phenylcarbamate production. Reduces energy consumption and simplifies separation for reliable supply chain partners.
Patent CN110028403A reveals visible light dicarboxylation. Offers mild conditions and scalable succinic acid manufacturing for pharma intermediates.
Patent CN100554269C reveals a Lewis acid-catalyzed route for triazole pyrimidines, offering high purity and reduced corrosion for agrochemical intermediate manufacturing.
Novel synthesis of lappaconitine acetal derivatives offers mild conditions and high safety for scalable antitumor pharmaceutical intermediates manufacturing supply chains.
Patent CN115368238A reveals a catalyst-free visible light method for trans-olefins. Achieves >100:1 stereoselectivity at room temperature, offering significant cost reduction.
Novel phase transfer catalysis method for allyl isovalerate ensures high yield and reduced waste. Reliable supply chain partner for synthetic flavor manufacturers seeking cost efficiency.
Patent CN106632365B reveals a novel one-pot synthesis for high-purity lappaconitine-isatin hybrids, offering significant supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110845371A reveals a novel ambient pressure synthesis for o-sulfonic acid benzaldehyde, offering significant cost reduction and safer manufacturing for pharmaceutical intermediates.